Instructor, Medicine, University of Washington School of Medicine
Endocrinology
Dr. Jayalakshmi Udayasankar, MD
|
|
Give Review
Dr. Jayalakshmi Udayasankar practices Endocrinology. She studied medicine at Kilpauk Medical College. Jayalakshmi Udayasankar is also a published doctor. She has 19 paper published. The most recent paper is: Rosiglitazone Treatment Does Not Decrease Amyloid Deposition in Transplanted Islets From Transgenic Mice Expressing Human Islet Amyloid Polypeptide. She accepts Medicare payments and is listed with Medicare.gov.
Publications
- Matrix metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide.
- Rosiglitazone Treatment Does Not Decrease Amyloid Deposition in Transplanted Islets From Transgenic Mice Expressing Human Islet Amyloid Polypeptide.
- cJUN N-terminal kinase (JNK) activation mediates islet amyloid-induced beta cell apoptosis in cultured human islet amyloid polypeptide transgenic mouse islets.
- β-cell loss and β-cell apoptosis in human type 2 Diabetes are related to islet amyloid deposition.
- Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets.
- Neprilysin impedes islet amyloid formation by inhibition of fibril formation rather than peptide degradation.
- Body mass index is associated With increased creatinine clearance by a mechanism independent of body fat distribution.
- Amyloid formation in human IAPP transgenic mouse islets and pancreas, and human pancreas, is not associated With endoplasmic reticulum stress.
- Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis.
- Amyloid formation results in recurrence of hyperglycaemia following transplantation of human IAPP transgenic mouse islets.
- Within-subject variability of measures of beta cell function derived from a 2 h OGTT: implications for research studies.
- The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta-cell function and insulin sensitivity in subjects With impaired fasting glucose.
- Inhibition of glycosaminoglycan synthesis and protein glycosylation With WAS-406 and azaserine result in reduced islet amyloid formation in vitro.
- Identification of the amyloid-degrading enzyme neprilysin in mouse islets and potential role in islet amyloidogenesis.
- Glucose- and time-dependence of islet amyloid formation in vitro.
- Plasma pancreatic polypeptide levels are associated With differences in body fat distribution in human subjects.
- Superiority of the Modification of Diet in Renal Disease equation over the Cockcroft-Gault equation in screening for impaired kidney function in Japanese Americans.
- Effects of sex and hormone replacement therapy use on the prevalence of isolated impaired fasting glucose and isolated impaired glucose tolerance in subjects With a fa...
Conditions Treated
- AdRenal Insufficiency
- Calcium Metabolism Disorders
- Conn's Syndrome
- Diabetes Type 1
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Education
-
University of Washington -
Kilpauk Medical College
Drug Facts
| NPI NUMBER | 1689785545 | |
| NPPES Provider LastName | UDAYASANKAR | |
| NPPES Provider FirstName | JAYALAKSHMI | |
| NPPES Provider ZIPCode | 980296201 | |
| NPPES Provider State | WA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 1693.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1689785545 |
| Last Name Of The Provider | UDAYASANKAR |
| First Name Of The Provider | JAYALAKSHMI |
| View All |
Similar Doctors
|
|
Dr. Bindu M. Nayak, MD
 This Doctor is OpenDoctor Recommended.
|